Supporting Publications

Azenosertib (WEE1 Inhibitor)

Loss of RB1 Sensitizes TP53‑Mutated Cancer Cells to WEE1 Inhibition by Azenosertib

Kim, D. et. al.
(
2025
)
American Association for Cancer Research

Cyclin E1 Positive Staining Is Frequent and Independent of Prior Platinum Treatment in High Grade Serous Ovarian Cancer

Harismendy, O. et al.
(
2023
)
American Association for Cancer Research Special Conference: Ovarian Cancer